Variant report

Variant	nsv2006
Chromosome Location	chr17:20846763-20892730
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:476)
CpG islands
(count:122)
Chromatin interactive
region (count:10)
LncRNA
region (count:40)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:476 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:20868924-20869171	HepG2	liver:	n/a	n/a
2	ATF1	chr17:20883000-20883363	K562	blood:	n/a	n/a
3	BHLHE40	chr17:20883062-20883311	K562	blood:	n/a	n/a
4	BRCA1	chr17:20847638-20847897	Hela-S3	cervix:	n/a	n/a
5	CCNT2	chr17:20883006-20883323	K562	blood:	n/a	n/a
6	CEBPB	chr17:20861895-20862228	HepG2	liver:	n/a	n/a
7	CEBPB	chr17:20858803-20859070	A549	lung:	n/a	chr17:20858901-20858914
8	CEBPB	chr17:20847162-20847609	H1-hESC	embryonic stem cell:	n/a	chr17:20847333-20847344
9	CEBPB	chr17:20847215-20847415	HepG2	liver:	n/a	chr17:20847333-20847344
10	CEBPB	chr17:20858776-20859128	Hela-S3	cervix:	n/a	chr17:20858901-20858914
11	CEBPB	chr17:20850189-20850297	A549	lung:	n/a	n/a
12	CEBPB	chr17:20850183-20850387	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr17:20858775-20859084	IMR90	lung:	n/a	chr17:20858901-20858914
14	CEBPB	chr17:20891991-20892012	HepG2	liver:	n/a	n/a
15	CEBPB	chr17:20861946-20862192	Hela-S3	cervix:	n/a	n/a
16	CEBPB	chr17:20859410-20859633	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr17:20861921-20862194	IMR90	lung:	n/a	n/a
18	CEBPB	chr17:20847327-20847911	Hela-S3	cervix:	n/a	chr17:20847333-20847344
19	CEBPB	chr17:20861905-20862232	A549	lung:	n/a	n/a
20	CEBPD	chr17:20883049-20883400	K562	blood:	n/a	n/a
21	CREB1	chr17:20871072-20871399	GM12878	blood:	n/a	chr17:20871260-20871273
22	CTCF	chr17:20847592-20847919	K562	blood:	n/a	n/a
23	CTCF	chr17:20847640-20847790	SK-N-SH_RA	brain:	n/a	n/a
24	CTCF	chr17:20847667-20847853	GM13977	blood:	n/a	n/a
25	CTCF	chr17:20847660-20847810	GM12869	blood:	n/a	n/a
26	CTCF	chr17:20847660-20847810	GM06990	blood:	n/a	n/a
27	CTCF	chr17:20878140-20878290	Hela-S3	cervix:	n/a	chr17:20878186-20878195
28	CTCF	chr17:20891544-20891726	MCF-7	breast:	n/a	chr17:20891603-20891624
29	CTCF	chr17:20847640-20847790	HRE	kidney:	n/a	n/a
30	CTCF	chr17:20847640-20847790	HCT-116	colon:	n/a	n/a
31	CTCF	chr17:20847595-20847922	MCF-7	breast:	n/a	n/a
32	CTCF	chr17:20883740-20883890	GM12871	blood:	n/a	n/a
33	CTCF	chr17:20847640-20847790	HVMF	connective:	n/a	n/a
34	CTCF	chr17:20847620-20847770	K562	blood:	n/a	n/a
35	CTCF	chr17:20847680-20847830	AG04450	lung:	n/a	n/a
36	CTCF	chr17:20847820-20847970	A549	lung:	n/a	n/a
37	CTCF	chr17:20847654-20847843	GM10248	blood:	n/a	n/a
38	CTCF	chr17:20847620-20847770	GM12872	blood:	n/a	n/a
39	CTCF	chr17:20891554-20891701	Hela-S3	cervix:	n/a	chr17:20891603-20891624
40	CTCF	chr17:20847520-20847670	HVMF	connective:	n/a	n/a
41	CTCF	chr17:20847729-20847802	Fibrobl	skin:	n/a	n/a
42	CTCF	chr17:20847560-20847710	GM12870	blood:	n/a	n/a
43	CTCF	chr17:20847720-20847870	GM12866	blood:	n/a	n/a
44	CTCF	chr17:20847660-20847810	GM12875	blood:	n/a	n/a
45	CTCF	chr17:20847528-20847977	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr17:20891520-20891670	WERI-Rb-1	eye:	n/a	chr17:20891603-20891624
47	CTCF	chr17:20847626-20847906	GM12878	blood:	n/a	n/a
48	CTCF	chr17:20847628-20847898	LNCaP	prostate:	n/a	n/a
49	CTCF	chr17:20847660-20847810	BE2_C	brain:	n/a	n/a
50	CTCF	chr17:20847740-20847890	HPAF	blood vessel:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20846889-20846939	RPTEC	kidney:	n/a
2	chr17:20846889-20846939	AG10803	skin:	n/a
3	chr17:20846889-20846939	ECC-1	luminal epithelium:	n/a
4	chr17:20846889-20846939	AG04450	lung:	fetal
5	chr17:20887220-20887270	BJ	skin:	n/a
6	chr17:20846889-20846939	HAEpiC	amniotic membrane:	n/a
7	chr17:20846889-20846939	MCF10A-Er-Src	breast:	n/a
8	chr17:20846889-20846939	SK-N-SH	brain:	n/a
9	chr17:20887220-20887270	K562	blood:	n/a
10	chr17:20846889-20846939	NHDF-neo	bronchial:	n/a
11	chr17:20887220-20887270	NT2-D1	testis:	n/a
12	chr17:20887220-20887270	HMEC	breast:	n/a
13	chr17:20846889-20846939	H1-hESC	embryonic stem cell:	embryo
14	chr17:20846889-20846939	GM06990	blood:	n/a
15	chr17:20887220-20887270	HepG2	liver:	n/a
16	chr17:20846889-20846939	BJ	skin:	n/a
17	chr17:20887220-20887270	NH-A	brain:	n/a
18	chr17:20887220-20887270	AG10803	skin:	n/a
19	chr17:20887220-20887270	PANC-1	pancreas:	n/a
20	chr17:20887220-20887270	Caco-2	colon:	n/a
21	chr17:20887220-20887270	AG09319	gingival:	n/a
22	chr17:20887220-20887270	Hepatocyte	liver:	n/a
23	chr17:20846889-20846939	PANC-1	pancreas:	n/a
24	chr17:20887220-20887270	GM12892	blood:	n/a
25	chr17:20846889-20846939	T-47D	breast:	n/a
26	chr17:20846889-20846939	NHBE	bronchial:	n/a
27	chr17:20887220-20887270	HRPEpiC	eye:	n/a
28	chr17:20846889-20846939	GM12878	blood:	n/a
29	chr17:20846889-20846939	MCF-7	breast:	n/a
30	chr17:20846889-20846939	HCF	heart:	n/a
31	chr17:20887220-20887270	HRCEpiC	kidney:	n/a
32	chr17:20846889-20846939	U87	brain:	n/a
33	chr17:20887220-20887270	HAEpiC	amniotic membrane:	n/a
34	chr17:20846889-20846939	BE2_C	brain:	n/a
35	chr17:20887220-20887270	CMK	blood:	n/a
36	chr17:20887220-20887270	PFSK-1	brain:	n/a
37	chr17:20846889-20846939	Hela-S3	cervix:	n/a
38	chr17:20846889-20846939	NT2-D1	testis:	n/a
39	chr17:20887220-20887270	GM19239	blood:	n/a
40	chr17:20846889-20846939	HCPEpiC	choroid plexus:	n/a
41	chr17:20887220-20887270	PrEC	prostate:	n/a
42	chr17:20846889-20846939	NB4	blood:	n/a
43	chr17:20887220-20887270	BE2_C	brain:	n/a
44	chr17:20846889-20846939	SK-N-MC	brain:	n/a
45	chr17:20846889-20846939	AG09319	gingival:	n/a
46	chr17:20887220-20887270	NHDF-neo	bronchial:	n/a
47	chr17:20887220-20887270	AG04450	lung:	fetal
48	chr17:20887220-20887270	AG04449	skin:	fetal
49	chr17:20887220-20887270	NHBE	bronchial:	n/a
50	chr17:20887220-20887270	T-47D	breast:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:20858081..20860827-chr17:20861654..20864252,2	MCF-7	breast:
2	chr17:20830020..20832888-chr17:20849310..20850863,2	K562	blood:
3	chr17:20839289..20841675-chr17:20882909..20885590,2	MCF-7	breast:
4	chr13:36918860..36921320-chr17:20868689..20871497,2	K562	blood:
5	chr17:20868249..20870031-chr17:20870854..20873494,2	K562	blood:
6	chr17:20868249..20870031-chr17:20870854..20873494,2	K562	blood:
7	chr17:20847224..20848217-chr17:20895812..20896910,8	MCF-7	breast:
8	chr17:20889603..20892267-chr17:20894765..20897394,3	MCF-7	breast:
9	chr17:20847348..20848179-chr17:20896234..20896805,2	MCF-7	breast:
10	chr17:20846131..20848515-chr17:20895317..20897201,2	MCF-7	breast:

(count:40 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHRS7B-5	chr17:20859507-20859666	ENSG00000233098.3
2	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
3	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
4	lnc-DHRS7B-5	chr17:20852416-20852754	ENSG00000264660.1
5	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
6	lnc-DHRS7B-5	chr17:20861615-20861660	ENSG00000233098.3
7	lnc-DHRS7B-5	chr17:20859507-20859666	ENSG00000264660.1
8	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
9	lnc-DHRS7B-5	chr17:20854744-20854834	ENSG00000233098.3
10	lnc-DHRS7B-5	chr17:20884800-20884937	ENSG00000233098.3
11	lnc-DHRS7B-5	chr17:20859130-20859666	ENSG00000233098.3
12	lnc-DHRS7B-5	chr17:20884800-20885670	ENSG00000264660.1
13	lnc-DHRS7B-5	chr17:20859947-20859969	NONHSAT146865
14	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
15	lnc-DHRS7B-5	chr17:20861615-20861702	ENSG00000233098.3
16	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000264660.1
17	lnc-DHRS7B-5	chr17:20861615-20861715	ENSG00000233098.3
18	lnc-DHRS7B-5	chr17:20857205-20859807	NONHSAT146865
19	lnc-DHRS7B-5	chr17:20861615-20861639	ENSG00000233098.4
20	lnc-DHRS7B-5	chr17:20861615-20861715	ENSG00000233098.3
21	lnc-DHRS7B-5	chr17:20859279-20859666	ENSG00000233098.3
22	lnc-DHRS7B-5	chr17:20884800-20884937	ENSG00000233098.3
23	lnc-DHRS7B-5	chr17:20861615-20861715	ENSG00000233098.3
24	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
25	lnc-DHRS7B-5	chr17:20859130-20859666	ENSG00000233098.4
26	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.3
27	lnc-DHRS7B-4	chr17:20867035-20867100	ENSG00000264660.1
28	lnc-DHRS7B-5	chr17:20861615-20862034	ENSG00000233098.3
29	lnc-DHRS7B-5	chr17:20852416-20852754	ENSG00000233098.3
30	lnc-DHRS7B-5	chr17:20861615-20861715	ENSG00000233098.3
31	lnc-DHRS7B-5	chr17:20859607-20859666	ENSG00000233098.3
32	lnc-DHRS7B-5	chr17:20861615-20861715	ENSG00000233098.3
33	lnc-DHRS7B-5	chr17:20859279-20859666	ENSG00000233098.3
34	lnc-DHRS7B-5	chr17:20859507-20859666	ENSG00000233098.3
35	lnc-DHRS7B-5	chr17:20859947-20860022	ENSG00000233098.4
36	lnc-DHRS7B-4	chr17:20882997-20883551	ENSG00000264660.1
37	lnc-DHRS7B-5	chr17:20859947-20860031	ENSG00000233098.3
38	lnc-DHRS7B-5	chr17:20884800-20884937	ENSG00000233098.3
39	lnc-DHRS7B-5	chr17:20859507-20859666	ENSG00000233098.3
40	lnc-DHRS7B-5	chr17:20861615-20861715	ENSG00000264660.1

No data

Variant related genes	Relation type
ENSG00000233098	TF binding region
ENSG00000264660	TF binding region
ENSG00000266009	TF binding region
ENSG00000244456	TF binding region
ENSG00000263729	TF binding region
ENSG00000233098	CpG island
ENSG00000264660	CpG island
ENSG00000266009	CpG island
ENSG00000244456	CpG island
ENSG00000263729	CpG island
ENSG00000133104	chromatin interactions
ENSG00000244456	chromatin interactions
ENSG00000120664	chromatin interactions
ENSG00000265099	chromatin interactions
ENSG00000233098	chromatin interactions

Extended variants
information (count: 1814 )
Associated
traits (count: 152 )

Variant overlapped rSNPs/rCNVs (count:1814 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs530154056	chr17:20846817-20846818	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs148282601	chr17:20846827-20846828	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs141326752	chr17:20846831-20846832	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs150790758	chr17:20846889-20846890	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs187008699	chr17:20846933-20846934	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs191434861	chr17:20846948-20846949	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs538105541	chr17:20847006-20847007	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs540917648	chr17:20847014-20847015	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs184330215	chr17:20847026-20847027	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs575146869	chr17:20847102-20847103	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs137922767	chr17:20847106-20847107	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs142299962	chr17:20847123-20847124	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs572966134	chr17:20847146-20847147	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs199502677	chr17:20847155-20847156	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs540478746	chr17:20847162-20847163	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs564261135	chr17:20847191-20847192	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs565026886	chr17:20847198-20847199	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs190440848	chr17:20847215-20847216	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs544462323	chr17:20847303-20847304	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs533088711	chr17:20847304-20847305	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs77964403	chr17:20847316-20847317	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs548275917	chr17:20847352-20847353	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs566997096	chr17:20847373-20847374	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs527730527	chr17:20847385-20847386	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs79675957	chr17:20847386-20847387	Enhancers Genic enhancers Weak transcription Strong transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs11651078	chr17:20847423-20847424	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs139860396	chr17:20847463-20847464	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs114328605	chr17:20847611-20847612	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs568643617	chr17:20847613-20847614	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs143835514	chr17:20847619-20847620	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs552954503	chr17:20847651-20847652	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs572978109	chr17:20847675-20847676	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs144773158	chr17:20847677-20847678	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs558802528	chr17:20847735-20847736	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs577085434	chr17:20847774-20847775	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs374348072	chr17:20847800-20847801	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs377543072	chr17:20847801-20847802	Enhancers Genic enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs544057083	chr17:20847838-20847839	Enhancers Genic enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs562838111	chr17:20847870-20847871	Enhancers Genic enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs62055504	chr17:20847962-20847963	Enhancers Genic enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs182312443	chr17:20848078-20848079	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs185269298	chr17:20848097-20848098	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs188913166	chr17:20848107-20848108	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs527793345	chr17:20848119-20848120	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs552222978	chr17:20848134-20848135	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs181405718	chr17:20848152-20848153	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs531819849	chr17:20848160-20848161	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs550096230	chr17:20848162-20848163	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs568781507	chr17:20848210-20848211	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs9906056	chr17:20848238-20848239	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:152)

Disease	PMID	Source
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Autism	20808228	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:365 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20827200-20856200	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr17:20831000-20846800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
3	chr17:20831000-20847200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr17:20831400-20847000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
5	chr17:20832400-20847800	Weak transcription	Gastric	stomach
6	chr17:20834200-20846800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
7	chr17:20834600-20847200	Weak transcription	H1 Cell Line	embryonic stem cell
8	chr17:20834600-20847800	Weak transcription	H9 Cell Line	embryonic stem cell
9	chr17:20835600-20869000	Weak transcription	HepG2	liver
10	chr17:20838600-20852400	Weak transcription	K562	blood
11	chr17:20841600-20847400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr17:20843200-20852200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr17:20844600-20847600	Weak transcription	Placenta	Placenta
14	chr17:20845400-20847200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr17:20845600-20847200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr17:20846600-20856200	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr17:20846800-20848000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
18	chr17:20846800-20848200	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr17:20846800-20848400	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr17:20847000-20847200	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr17:20847000-20847400	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr17:20847000-20847600	Weak transcription	Rectal Mucosa Donor 31	rectum
23	chr17:20847200-20847600	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr17:20847200-20847600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
25	chr17:20847200-20847800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr17:20847200-20848200	Enhancers	H1 Cell Line	embryonic stem cell
27	chr17:20847200-20848200	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr17:20847200-20848200	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr17:20847200-20848200	Enhancers	HUES6 Cell Line	embryonic stem cell
30	chr17:20847200-20848200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr17:20847200-20848200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr17:20847200-20848200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr17:20847400-20847600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
34	chr17:20847400-20847600	Bivalent Enhancer	A549	lung
35	chr17:20847400-20847800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
36	chr17:20847400-20847800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
37	chr17:20847400-20847800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr17:20847400-20847800	Bivalent Enhancer	Stomach Mucosa	stomach
39	chr17:20847400-20848200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr17:20847400-20848200	Enhancers	Hela-S3	cervix
41	chr17:20847600-20848000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr17:20847600-20848200	Enhancers	Placenta	Placenta
43	chr17:20847600-20848200	Enhancers	Rectal Mucosa Donor 31	rectum
44	chr17:20847600-20848400	Enhancers	iPS-15b Cell Line	embryonic stem cell
45	chr17:20847800-20848000	Enhancers	H9 Cell Line	embryonic stem cell
46	chr17:20847800-20848000	Enhancers	Esophagus	oesophagus
47	chr17:20847800-20848200	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr17:20847800-20848200	Enhancers	Gastric	stomach
49	chr17:20847800-20848200	Enhancers	Pancreas	Pancrea
50	chr17:20847800-20869400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links